Scarica l'app Stockscreener
482.08
2.42%
-11.96
Dopo l'orario di chiusura:
482.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$494.04
Aprire:
$489.42
Volume 24 ore:
1.78M
Relative Volume:
0.79
Capitalizzazione di mercato:
$179.15B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
26.50
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
+7.56%
1M Prestazione:
+2.74%
6M Prestazione:
-16.94%
1 anno Prestazione:
+21.59%
Intervallo 1D:
$476.51
$491.96
Intervallo di 1 settimana:
$447.44
$499.00
Portata 52W:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
482.08 | 183.60B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
176.11 | 127.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
550.82 | 44.71B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.05 | 38.38B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
371.93 | 37.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.01% on Jun 2: Key Drivers Unveiled - TradingKey
Mettler-Toledo International vs Thermo Fisher Scientific: Which Is the Stronger Buy Today? - Trefis
Is Thermo Fisher Scientific (TMO) Pricing Look Interesting After Recent Share Price Swings - Yahoo Finance
The Zacks Analyst Blog Highlights Microsoft, Dell, Thermo Fisher,Village Super Market and Comstock - Yahoo Finance
Thermo Fisher expands Orbitrap innovation across research, biopharma and applied testing - BioSpectrum Asia
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - BioSpace
Thermo Fisher Scientific introduces expanded Orbitrap solutions for research and applied sciences - BioSpectrum Asia
West Pharma names former Thermo Fisher executive Lagarde as CEO - WSAU
Wolfe Research initiates Thermo Fisher stock coverage with Outperform rating - Investing.com
Wolfe Research initiates Thermo Fisher stock coverage with Outperform rating By Investing.com - Investing.com Canada
Top Analyst Reports for Microsoft, Dell & Thermo Fisher - Yahoo Finance
Thermo Fisher Scientific (TMO) Stock Valuation Analysis Reveals Mixed Signals - GuruFocus
Thermo Fisher Scientific debuts Orbitrap and AI tools at ASMS 2026 - SelectScience
Thermo Fisher Unveils AI Orbitraps And Swedish Labs As Valuation Lags - Yahoo Finance
Thermo Fisher Scientific Stock: Why Analyst Consensus Is 27 Buys With Zero Sells - TIKR.com
Thermo Fisher Rose 10% This Week. Here’s What to Expect in 2026 - TIKR.com
Thermo Fisher Beats Black Worker’s Race, Sex Discrimination Suit - Bloomberg Law News
Thermo Fisher Scientific Hits Day High with 6.8% Intraday Surge - Markets Mojo
Fidelity files Form 144: TMO proposed sale of 45,940 shares (05/29/2026) - Stock Titan
Is Thermo Fisher Scientific Stock Underperforming the S&P 500? - Barchart
Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MSN
Thermo Fisher Scientific Inc (TMO) Stock Up 6.8% and Still Under - GuruFocus
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 5.14% on May 28: Drivers Behind the Movement - TradingKey
Thermo Fisher Launches E-Gel Power Snap Lite System - Contract Pharma
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 — Data Talk - Morningstar
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 -- Data Talk - Moomoo
Thermo Fisher (TMO) Unveils Advanced Mass Spectrometers at Key C - GuruFocus
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies - BioSpace
New Thermo Fisher AI tools aim to speed drug discovery workflows - Stock Titan
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating? - Insider Monkey
Thermo Fisher (TMO) Sets a Bold 7% Annual Growth Target at Its 2026 Investor Day - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $650 - Moomoo
[144] THERMO FISHER SCIENTIFIC INC. SEC Filing - Stock Titan
Thermo Fisher Scientific Inc. (TMO) Analyst/Investor DaySlideshow (NYSE:TMO) 2026-05-26 - Seeking Alpha
Thermo Fisher Scientific (TMO) Announces Results of Annual Share - GuruFocus
KeyBanc reiterates Thermo Fisher Scientific stock rating on AI tailwinds By Investing.com - Investing.com Canada
Thermo Fisher Scientific Inc. 8-K SEC Filing Details, Exchange Listings, and Security Information (May 20, 2026) - Minichart
Thermo Fisher Scientific Inc (TMO) Stock Price, Trades & News - GuruFocus
Thermo Fisher (NYSE: TMO) holders back board but reject 2026 executive pay proposal - Stock Titan
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Ambient Air Quality Monitoring is Helping Cities Tackle Urban Pollution - AZoCleantech
Thermo Fisher Scientific Inc. (TMO) Announces Opening of New Bioanalytical and Biomarker Laboratory in Gothenburg, Sweden - Insider Monkey
Thermo Fisher Scientific Inc Investor Day Transcript - GuruFocus
Did Thermo Fisher’s AI-Focused Investor Day and Clario Deal Just Redefine TMO’s Investment Narrative? - simplywall.st
Thermo Fisher (TMO) director gets 499-share award, 80 withheld for tax - Stock Titan
Director at Thermo Fisher (NYSE: TMO) granted new shares - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 499-share stock award - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 499-share equity grant - Stock Titan
Thermo Fisher (TMO) director receives 499-share stock grant, now holds 2,602 - Stock Titan
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):